Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EAA/T vs drug therapy in children with ADHD
NCT02482649Unknown
- Sponsor
- Samsung Medical Center
- Start
- Jan 2013
- Primary completion
- Aug 2015
- Countries
- 1
01
Overview
Randomised, open-label trial in attention deficit hyperactivity disorder (ADHD), sponsored by Samsung Medical Center. Primary endpoints: ADHD Rating Scale - Investigator at 12 weeks and Treatment Response Rate at 12 weeks. Status: unknown.
02
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT02482649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02482649.